ALAGNIVO Trademark

Trademark Overview

On Friday, July 21, 2017, a trademark application was filed for ALAGNIVO with the United States Patent and Trademark Office. The USPTO has given the ALAGNIVO trademark a serial number of 87537822. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 15, 2021. This trademark is owned by Bristol-Myers Squibb Company. The ALAGNIVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
alagnivo

General Information

Serial Number87537822
Word MarkALAGNIVO
Filing DateFriday, July 21, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, November 15, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, April 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 1, 2021EXTENSION 5 GRANTED
Tuesday, March 30, 2021EXTENSION 5 FILED
Tuesday, March 30, 2021TEAS EXTENSION RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021EXTENSION 4 GRANTED
Friday, October 9, 2020EXTENSION 4 FILED
Tuesday, February 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 11, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, November 10, 2020EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 10, 2020PETITION TO REVIVE-GRANTED
Tuesday, November 10, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, November 9, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 9, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 9, 2020EXTENSION 3 GRANTED
Thursday, April 9, 2020EXTENSION 3 FILED
Thursday, April 9, 2020TEAS EXTENSION RECEIVED
Friday, October 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2019EXTENSION 2 GRANTED
Wednesday, October 9, 2019EXTENSION 2 FILED
Wednesday, October 9, 2019TEAS EXTENSION RECEIVED
Saturday, March 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2019EXTENSION 1 GRANTED
Thursday, March 28, 2019EXTENSION 1 FILED
Thursday, March 28, 2019TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 28, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 26, 2018ASSIGNED TO LIE
Tuesday, June 12, 2018NOTICE OF REVIVAL - E-MAILED
Monday, June 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 11, 2018PETITION TO REVIVE-GRANTED
Monday, June 11, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 5, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, June 5, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, October 23, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 23, 2017NON-FINAL ACTION E-MAILED
Monday, October 23, 2017NON-FINAL ACTION WRITTEN
Friday, October 20, 2017ASSIGNED TO EXAMINER
Thursday, July 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

alagnivo diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection